BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/7/2023 8:12:13 AM | Browse: 360 | Download: 1095
 |
Received |
|
2022-11-26 22:01 |
 |
Peer-Review Started |
|
2022-11-26 22:07 |
 |
First Decision by Editorial Office Director |
|
2023-01-17 01:16 |
 |
Return for Revision |
|
2023-01-17 01:16 |
 |
Revised |
|
2023-01-27 03:26 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2023-02-21 03:42 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2023-02-21 07:21 |
 |
Articles in Press |
|
2023-02-21 07:21 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2023-02-27 09:24 |
 |
Publish the Manuscript Online |
|
2023-03-07 08:12 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Critical Care Medicine |
| Manuscript Type |
Minireviews |
| Article Title |
Evolving paradigm of thrombolysis in pulmonary embolism: Comprehensive review of clinical manifestations, indications, recent advances and guideline
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Rohan Kumar Ochani, Rafi Aibani, Hafsa Nazir Jatoi, Masroor Anwar, Syed Anjum Khan, Iqbal Ratnani and Salim Surani |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Salim Surani, FCCP, MD, MS, Professor, Department of Medicine, Texas A&M University, Administration Building, 400 Bizzell St, College Station, TX 77843, United States. srsurani@hotmail.com |
| Key Words |
Pulmonary Embolism; Thrombolytics; Systemic; Catheter-directed; Pulmonary Embolism Reaction Team; Guidelines |
| Core Tip |
There are now many treatments to treat acute pulmonary embolism (PE). Patients are divided into low, moderate, and high-risk PE groups to identify those needing more advanced treatment. Unless contraindicated, systemic thrombolysis is advised for high-risk pulmonary embolism. Other than systemic thrombolysis, a number of treatment options for PE are being investigated, such as catheter-directed thrombolysis, extracorporeal membrane oxygenation, direct aspiration, or fragmentation with aspiration. Choosing the appropriate course of treatment for a certain patient may be challenging due to the plethora of therapeutic choices that are continually evolving and the paucity of randomized controlled trials. Therefore, the Pulmonary Embolism Reaction Team, is a multidisciplinary, rapid response team has been developed and is employed by various institutions to customize therapeutic options according to the need of the patient to address the ever-evolving therapeutic care. |
| Publish Date |
2023-03-07 08:12 |
| Citation |
Ochani RK, Aibani R, Jatoi HN, Anwar M, Khan SA, Ratnani I, Surani S. Evolving paradigm of thrombolysis in pulmonary embolism: Comprehensive review of clinical manifestations, indications, recent advances and guideline. World J Clin Cases 2023; 11(8): 1702-1711 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i8/1702.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i8.1702 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.